Our collaborators – Professor Mark Sculpher

Professor Mark Sculpher is Professor of Health Economics in the Centre for Health Economics at the University of York, and is Director of the Programme on Economic Evaluation and Health Technology Assessment. He has been based at York University since 1997. Between 1988 and 1997, he worked at the Health Economics Research Group at Brunel University; during 1998 he was a visitor in the Department of Clinical Epidemiology and Biostatistics at McMaster University in Canada.

Mark has worked on economic evaluations of a range of technologies including heart disease and various cancers. He has also contributed to methods in the field, in particular relating to decision analytic modelling and handling uncertainty.

Mark was a member of the National Institute for Health and Clinical Excellence (NICE) Technology Appraisal Committee between 2004 and 2008, the NICE Public Health Interventions Advisory Committee between 2006 and 2009 and currently sits on the NICE Diagnostics Advisory Committee. He chaired NICE's 2004 Task Group on methods guidance for economic evaluation and was a member of the Methods Working Party for the 2008 update of this guidance. He was a member of the Commissioning Board for the UK NHS Health Technology Assessment Programme between 2007 and 2010, and currently participates in the UK NIHR/Medical Research Council’s Methodology Panel. Mark is a National Institute for Health Research Senior Investigator and is currently President-Elect of the International Society of Pharmacoeconomics and Outcomes Research.


Current projects

Involvement in the Public Health Research Consortium

For more information on the projects below, please visit Mark Sculpher’s profile page on the Public Health Research Consortium website accessed here.


  • Member of the PHRC Project Management Group, 2011-
  • Principal Investigator: Identifying appropriate methods to incorporate concerns about health inequalities into economic evaluations of health care programme
  • Principal Investigator: The economic evaluation of public health programmes with costs and effects falling outside the NHS and local authority public health budgets

For more information on the Public Health Research Consortium please visit: www.phrc.online